Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial-Reference-Cited by-同舟云学术

Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial

Published:1985-01 Issue:1 Volume:78 Page:9-14
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Frieri Marianne,Alling David W.,Metcalfe Dean D.

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. The mastocytosis syndrome;Parker,1979

2. Systemic mastocytosis: control of lifelong diarrhea by ingested disodium cromoglycate;Dolovich;J Can Med Assoc,1974

3. Disodium cromoglycate (Intel) for the symptomatic treatment of generalized mastocytosis;Volkel;Int Med,1977

4. Oral disodium cromoglycate in the treatment of systemic mastocytosis;Soter;N Engl J Med,1979

5. Urticaria pigmentosa: treatment with cimetidine and chlorpheniramine;Gerrard;J Pediatr,1979

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cell–Targeting Therapies in Mast Cell Activation Syndromes;Current Allergy and Asthma Reports;2024-01-13

2. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome;The Journal of Allergy and Clinical Immunology: In Practice;2020-09

3. Paediatric Mastocytosis;Harper's Textbook of Pediatric Dermatology;2019-11-20

4. Hereditary Alpha Tryptasemia;Immunology and Allergy Clinics of North America;2018-08

5. Pharmacotherapy of mast cell disorders;Current Opinion in Allergy & Clinical Immunology;2017-08